Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori.

Bekar O, Yilmaz Y, Gulten M.

J Med Food. 2011 Apr;14(4):344-7. doi: 10.1089/jmf.2010.0099. Epub 2010 Dec 27.

PMID:
21186984
2.
3.
4.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
5.

Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.

Wong BC, Xiao SD, Hu FL, Qian SC, Huang NX, Li YY, Hu PJ, Daldiyono, Manan C, Lesmana L, Carpio RE, Perez JY Jr, Fock KM, Kachintorn U, Phornphutkul K, Kullavanijaya P, Ho J, Lam SK.

Aliment Pharmacol Ther. 2000 Feb;14(2):217-24.

6.

Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.

Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.

Helicobacter. 2008 Dec;13(6):542-9. doi: 10.1111/j.1523-5378.2008.00648.x.

PMID:
19166420
7.

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.

Lee VW, Chau TS, Chan AK, Lee KK, Waye MM, Ling TK, Chan FK.

J Clin Pharm Ther. 2010 Jun;35(3):343-50. doi: 10.1111/j.1365-2710.2009.01088.x.

PMID:
20831535
8.

Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.

Aliment Pharmacol Ther. 2002 Jan;16(1):153-8.

9.

Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.

Srinarong C, Siramolpiwat S, Wongcha-um A, Mahachai V, Vilaichone RK.

Asian Pac J Cancer Prev. 2014;15(22):9909-13.

10.

Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.

Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, Lee SM, Hahm KB, Lee SM, Jeong JY, Yun SC.

J Gastroenterol Hepatol. 2012 Nov;27(11):1675-80. doi: 10.1111/j.1440-1746.2012.07249.x.

PMID:
22849546
11.

[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].

Lamouliatte H, Perie F, Joubert-Collin M.

Gastroenterol Clin Biol. 2000 May;24(5):495-500. French.

12.
13.

Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.

Turk J Gastroenterol. 2005 Mar;16(1):29-33.

14.

A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.

Mansour NM, Hashash JG, El-Halabi M, Ghaith O, Maasri K, Sukkarieh I, Malli A, Sharara AI.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):865-70. doi: 10.1097/MEG.0b013e3283496502. Review.

PMID:
21811161
15.

The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.

Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.

J Dig Dis. 2007 Nov;8(4):211-5.

PMID:
17970879
16.
17.

Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.

Uygun A, Kadayifçi A, Yeşilova Z, Savaş MC, Ateş Y, Karslioğlu Y, Ciğerim M, Bağci S, Dağalp K.

Turk J Gastroenterol. 2004 Dec;15(4):219-24.

18.

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.

Assem M, El Azab G, Rasheed MA, Abdelfatah M, Shastery M.

Eur J Intern Med. 2010 Aug;21(4):310-4. doi: 10.1016/j.ejim.2010.05.011. Epub 2010 Jun 16.

PMID:
20603042
19.

Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.

Kim SY, Lee SW, Hyun JJ, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Choi JH.

J Clin Gastroenterol. 2013 Jan;47(1):21-4. doi: 10.1097/MCG.0b013e3182548ad4.

PMID:
22647826
20.
Items per page

Supplemental Content

Write to the Help Desk